Continuous Peripheral Nerve Block Catheters Market Size Projected to Reach $452.85 million by 2034 | 3.32%

According to Straits Research, the global continuous peripheral nerve block catheters market size was valued at $636.03 million in 2025 and is projected to grow from $677.14 million in 2026 to $1,117.61 million by 2034, exhibiting a CAGR of 6.46% during the forecast period 2026–2034.

Continuous Peripheral Nerve Block catheters are specialized medical devices designed to deliver prolonged pain relief by continuously administering local anesthetics directly to targeted peripheral nerves or nerve plexuses. The catheters are strategically placed near specific nerves, often using ultrasound guidance to ensure precise placement.

Once in position, they are connected to an infusion pump, which delivers a controlled dose of anesthetic medication, providing sustained pain control throughout the perioperative period. This technique is especially beneficial for managing postoperative pain, reducing the need for systemic opioids, and enhancing recovery.

Market Dynamics

Increasing preference for local anesthesia in surgeries drives the global market

Unlike general anesthesia, which affects the entire body and induces unconsciousness, Continuous Peripheral Nerve Block (CPNB) catheters provide targeted pain relief directly at the surgical site, minimizing the systemic effects on the patient and promoting quicker recovery. This approach is particularly advantageous in surgeries that require precise pain control, such as vascular procedures like atherectomy.

• A study published in January 2025 by the National Library of Medicine revealed the benefits of local anesthesia in geriatric hip fracture surgeries. The study highlighted that local anesthesia resulted in better pain management, faster recovery, and fewer complications when compared to general anesthesia. Moreover, it significantly reduced hospital stays and 30-day mortality rates, further confirming that local anesthesia is a safer and more effective option.

As healthcare professionals increasingly recognize the advantages of local anesthesia over general anesthesia, the use of CPNB catheters is expected to grow.

Increasing number of strategic collaborations creates tremendous opportunities

The increasing trend of strategic partnerships between medical device manufacturers, healthcare providers, and distribution networks is accelerating innovation and improving the availability of Continuous Peripheral Nerve Block (CPNB) catheters. These collaborations enhance distribution channels, drive technological advancements, and support the implementation of opioid-sparing pain management strategies in surgical settings.

• For example, in February 2022, InfuSystem Holdings, Inc., a prominent healthcare service provider, entered into a national distribution agreement with Solo-Dex, Inc. to distribute its proprietary continuous nerve block catheters. This partnership aims to expand access to advanced pain management solutions, particularly in outpatient care.

Regional Analysis

North America holds a dominant position in the global continuous peripheral nerve block catheters market, driven by the widespread adoption of regional anesthesia techniques and increasing surgical volumes. The region's advanced healthcare infrastructure, strong reimbursement policies, and innovations contribute significantly to market growth. The rising demand for orthopedic, trauma, and outpatient procedures, combined with the growing emphasis on minimizing opioid use and enhancing patient recovery, accelerates the adoption of CPNB catheters.

Market Segments

1. By Insertion Technique 
   1. Ultrasound
   2. Nerve Stimulation
   3. Hybrid
2. By Indication 
   1. Upper Extremity Surgery
   2. Lower Extremity Surgery
3. By End-User
   1. Hospitals
   2. Ambulatory Surgical Centers
   3. Others
4. By Regions
   1. North America
   2. Europe
   3. Asia-Pacific
   4. Central & South America
   5. The Middle East and Africa